The oral version is absorbed sublingually, placed under the tongue for 60 to 90 seconds and then swallowed, rather than injected, and is dosed differently to account for lower bioavailability through that route
Key considerations include: Watching for signs of pancreatitis or gallbladder disease Looking at the patients overall health and medical history Changing the dosage or stopping treatment if side effects happen In patients with a history of gallbladder disease or cholecystectomy, the decision to start or keep using GLP-1 receptor agonist therapy should be made on a case-by-case basis
Once you inject the medication into your body, the half-life of Wegovy is about one week
Muscle pain Semaglutide effect and fatigue can be caused by the buildup of lactic acid in muscles during the increase in physical activity
The results indicated a significant increased risk of cholelithiasis with the use of GLP-1 RAs when compared to placebo or active comparator
However, newer observational data suggest a real-world subset of patients may maintain their weight after stopping
